Skip to main content
SpringerLink
Log in

Renal denervation: a new treatment option in resistant arterial hypertension

  • Special Article
  • Published:
Netherlands Heart Journal Aims and scope Submit manuscript

Abstract

Hypertension is one of the most prevalent cardiovascular risk factors. Despite this high prevalence and a broad availability of effective pharmaceutical agents, a significant proportion of patients do not reach treatment goals. Partly this can be explained by secondary causes of hypertension or non-compliance of patients. Nevertheless, a subgroup of patients can be diagnosed with ‘resistant hypertension’. Activation of the sympathetic nervous system is known to be an important factor in the development and progression of systemic hypertension. In this context, a percutaneous, catheter–based approach has been developed using radiofrequency energy to disrupt renal sympathetic nerves. The first studies have shown this technique to be safe, illustrated by a lack of vascular or renal injury. More importantly, catheter-based renal nerve ablation resulted in a significant reduction in blood pressure on top of traditional medical therapy. Additional to the encouraging effects shown on hypertension, a positive influence of this intervention in other conditions, characterised by sympathetic overactivation, may be expected. Though this technique seems promising, further studies are needed to address long-term safety and efficacy of renal denervation in hypertension and other disease states.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–23.

    PubMed  Google Scholar 

  2. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010;303:2043–50.

    Article  PubMed  CAS  Google Scholar 

  3. Pereira M, Lunet N, Azevedo A, et al. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. 2009;27:963–75.

    Article  PubMed  CAS  Google Scholar 

  4. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510–26.

    Article  PubMed  Google Scholar 

  5. Doumas M, Papademetriou V, Douma S, et al. Benefits from treatment and control of patients with resistant hypertension. Int J Hypertens. 2010;2011:318549.

    PubMed  Google Scholar 

  6. Schlaich MP, Sobotka PA, Krum H, et al. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension. 2009;54:1195–201.

    Article  PubMed  CAS  Google Scholar 

  7. Anderson EA, Sinkey CA, Lawton WJ, et al. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension. 1989;14:177–83.

    Article  PubMed  CAS  Google Scholar 

  8. Siddiqi L, Joles JA, Grassi G, et al. Is kidney ischemia the central mechanism in parallel activation of the renin and sympathetic system? J Hypertens. 2009;27:1341–9.

    Article  PubMed  CAS  Google Scholar 

  9. Barajas L, Liu L, Powers K. Anatomy of the renal innervation: intrarenal aspects and ganglia of origin. Can J Physiol Pharmacol. 1992;70:735–49.

    Article  PubMed  CAS  Google Scholar 

  10. DiBona GF. Neural control of the kidney: past, present, and future. Hypertension. 2003;41(3 Pt 2):621–4.

    Article  PubMed  CAS  Google Scholar 

  11. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:75–197.

    PubMed  CAS  Google Scholar 

  12. Kopp U, Aurell M, Sjolander M, et al. The role of prostaglandins in the alpha- and beta-adrenoceptor mediated renin release response to graded renal nerve stimulation. Pflugers Arch. 1981;391:1–8.

    Article  PubMed  CAS  Google Scholar 

  13. Stella A, Zanchetti A. Functional role of renal afferents. Physiol Rev. 1991;71:659–82.

    PubMed  CAS  Google Scholar 

  14. Atherton DS, Deep NL, Mendelsohn FO. Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study. Clin Anat. 2012;25:628–33.

    Article  PubMed  Google Scholar 

  15. Tam GM, Yan BP, Shetty SV, et al. Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited. Int J Cardiol. 2012. doi:10.1016/j.ijcard.2012.01.048.

  16. Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension; results in 1,266 cases. J Am Med Assoc. 1953;152:1501–4.

    Article  PubMed  CAS  Google Scholar 

  17. Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension; review of 122 cases. Lancet. 1953;1(6757):403–8.

    Article  PubMed  CAS  Google Scholar 

  18. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81.

    Article  PubMed  Google Scholar 

  19. Voskuil M, Verloop WL, Blankestijn PJ, et al. Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience. Neth Heart J. 2011;19:319–23.

    Article  PubMed  CAS  Google Scholar 

  20. Esler MD, Krum H, Sobotka PA, et al. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet. 2010;376:1903–9.

    Article  PubMed  Google Scholar 

  21. Symplicity HTN-1 investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911–7.

    Google Scholar 

  22. Sobotka P. Symplicity HTN-1: long term follow-up of catheter-based renal sympathetic denervation for resistant hypertension confirms durable blood pressure reduction. 61st An-nual Scientific Session & Expo 2012. Chicago: Oral presentation at ACC; 2012.

  23. Egan BM. Renal sympathetic denervation: a novel intervention for resistant hypertension, insulin resistance, and sleep apnea. Hypertension. 2011;58:542–3.

    Article  PubMed  CAS  Google Scholar 

  24. Mahfoud F, Schlaich M, Kindermann I, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation. 2011;123:1940–6.

    Article  PubMed  CAS  Google Scholar 

  25. Brandt MC, Mahfoud F, Reda S, et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol. 2012;59:901–9.

    Article  PubMed  Google Scholar 

  26. Schlaich MP, Straznicky N, Grima M, et al. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens. 2011;29:991–6.

    Article  PubMed  CAS  Google Scholar 

  27. Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58:559–65.

    Article  PubMed  CAS  Google Scholar 

  28. Tsioufis C, Dimitriadis K, Tsiachris D, et al. Catheter-based renal sympathetic denervation for the treatment of resistant hypertension: first experience in Greece with significant ambulatory blood pressure reduction. Hellenic J Cardiol. 2012;53:237–41.

    PubMed  Google Scholar 

  29. Ahmed H, Neuzil P, Skoda J, et al. Renal sympathetic denervation using an irrigated radiofrequency ablation catheter for the management of drug-resistant hypertension. JACC Cardiovasc Interv. 2012;5:758–65.

    Article  PubMed  Google Scholar 

  30. Gaspar Hernandez J, Eid-Lidt G, Payro Ramirez G, et al. Renal sympathetic denervation (RSD): a new, non-pharmacologic therapeutic strategy for treatment-resistant hypertension (TRH). Report of the first procedure in Mexico. Gac Med Mex. 2012;148:125–9.

    PubMed  Google Scholar 

  31. Ong PJ, Foo D, Ho HH. Successful treatment of resistant hypertension with percutaneous renal denervation therapy. Heart. 2012;98(23):1754–5.

    Google Scholar 

  32. Simonetti G, Spinelli A, Gandini R, et al. Endovascular radiofrequency renal denervation in treating refractory arterial hypertension: a preliminary experience. Radiol Med. 2012;117:426–44.

    Article  PubMed  CAS  Google Scholar 

  33. Prochnau D, Figulla HR, Surber R. Efficacy of renal denervation with a standard EP catheter in the 24-h ambulatory blood pressure monitoring-long-term follow-up. Int J Cardiol. 2012;157:447–8.

    Article  PubMed  Google Scholar 

  34. Worthley S. Safety and efficacy of a novel quadrapolar renal denervation catheter in patients with resistant hypertension: a first-in-man multicentre study. Paris: Oral presentation at EuroPCR; 2012.

    Google Scholar 

  35. Margolis JR, Percutaneous RF. balloon-mediated renal denervation in under a minute: The V2 System by Vessix. Frankfurt: Oral presentation at TrenD; 2012.

    Google Scholar 

  36. Mabin TA. REDUCE First-In-Man clinical study. Frankfurt: Oral presentation at TrenD; 2012.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, UMC Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, the Netherlands

    W. L. Verloop, M. Voskuil & P. A. Doevendans

Authors
  1. W. L. Verloop
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Voskuil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. A. Doevendans
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. L. Verloop.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verloop, W.L., Voskuil, M. & Doevendans, P.A. Renal denervation: a new treatment option in resistant arterial hypertension. Neth Heart J 21, 95–98 (2013). https://doi.org/10.1007/s12471-012-0357-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12471-012-0357-8

Keywords

Search

Navigation